Cartesian Therapeutics, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $15.8M | $-39.2M | $-35.9M | $15.9M | $-17.7M | $-24.2M | $13.8M | $-56.8M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $800.0K | $600.0K | $600.0K | $600.0K | $600.0K | $300.0K | $200.0K | $200.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $2.4M | — | — | $2.5M | — | — | $1.4M |
| Net Cash from Operating Activities | $-21.1M | $-22.1M | $-15.6M | $-17.5M | $-23.1M | $13.7M | $-14.4M | $-15.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $272.0K | $27.0K | $1.3M | $2.6M | $1.1M | $6.2M | $1.6M | $602.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-27.0K | — | — | $-1.1M | — | — | $-602.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $15.7M | — | — | $-8.0M | — | — | $43.0M |
| Net Change in Cash | — | $-6.5M | — | — | $-32.2M | — | — | $26.5M |
| Free Cash Flow | $-21.4M | $-22.2M | $-16.9M | $-20.1M | $-24.2M | $7.5M | $-16.0M | $-16.5M |